Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: diseases + web + 0.32  Related to the article below (Last Update: 8/4/2008)

Tyson Reports Third Quarter and Nine Months Results
CNNMoney.com (press release) - Jul 28, 2008
... including currency fluctuations, import/export restrictions and foreign politics; (vi) outbreak of a livestock disease (such as avian influenza (AI) or ...TSN
UPI NewsTrack Business
United Press International - Jul 10, 2008
At midday, the Dow Jones industrial average was up 35.85 points to 11183.27, up 0.32 percent. The Standard and Poor's 500 index was up 4.94 points to ...
Source: Google News

Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q -
L Bertram, D Blacker, K Mullin, D Keeney, J Jones, … - Science, 2000 - sciencemag.org
... D10S1741 (128.2), 0.4 (0.29), 0.3 (0.32). ... signal at marker D10S1225 did not increase
[Web table 5 ... us to test this marker for allelic association with the disease. ...

Reliability of Web-based teledermatology consultations -
MO Oztas, E Calikoglu, K Baz, A Birol, M Onder, T … - Journal of Telemedicine and Telecare, 2004 - ingentaconnect.com
... from 44% to 70% (kappa was 0.22?0.32) (Table 4 ... Web-based teledermatology consultations
26 ... Fungal diseases 21 Viral diseases 18 Papulosquamous diseases 13 Skin ...

Primary prevention of cardiovascular disease: a web-based risk score for seven British black and … -
P Brindle, M May, P Gill, F Cappuccio, RD'Agostino … - British Medical Journal, 2006 - heart.bmj.com
... S minority ethnic groups web-based risk score for seven British black and
Primary prevention of cardiovascular disease: a http://heart ...

[PDF] Highly Endemic, Waterborne Toxoplasmosis in North -
LMG Bahia-Oliveira, JL Jones, J Azevedo-Silva, CCF … - Emerging Infectious Diseases, 2003 - origin.cdc.gov
... in many other developing countries, where the lack of adequate sanitary conditions
expose populations to a variety of diseases. ... Middle 0.48 0.32 0.72 <0.001 c ...
-


JC Takegami, JS Beaver, G Godoy-Lutz, R Echavez- … - Journal of Agriculture of the University of Puerto Rico, 2004 - cababstractsplus.org
... of resistance to web blight, a destructive disease caused by ... and laboratory tests
for reaction to web blight ... intermediate in magnitude, ranging from 0.32 to 0.53 ...

EFFECT OF EPIDEMIOLOGICAL PARAMETERS ON THE DEVELOPMENT OF WEB BLIGHT OF STRAWBERRY
LN Bhardwaj, R Bala, B Gupta - VII International Symposium on Temperate Zone Fruits in the …, 2003 - ISHS
... Plant Diseases : Epidemics and Control. ... Mean soil temperature -0.32 0.52 0.12 0.69*
0.90** 0.82** ... Table 2. Multiple correlation among web blight severity ...

Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease -
R Clarke, AD Smith, KA Jobst, H Refsum, L Sutton, … - Archives of Neurology, 1998 - Am Med Assoc
... Web browser does not support basic Web standards ... patients with histologically confirmed
Alzheimer disease (AD) and ... positively correlated with age (r=0.32, P=.001 ...

Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease -
C Paszty, CM Brion, E Manci, HE Witkowska, ME … - Science - sciencemag.org
... a browser that does not support current Web standards. ... NJ), Bed-O'Cobs bedding (size,
0.32 cm) (Andersons ... of Diabetes, Digestive and Kidney Diseases, a NHLBI ...

World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site- … -
GM Gobar, PH Kass - Journal of the American Veterinary Medical Association, 2002 - Am Vet Med Assoc
... of supplying answers to questions about disease incidence ... Procedure?Veterinarians
used secure Web-based survey ... 0.63 sarcomas/10,000 cats; 0.32 sarcomas/10,000 ...

LYME DISEASE
SANN CALL - Clinical Primer of Rheumatology, 2003 - books.google.com
... for Disease Control and Prevention, Division of Vector-Borne Infectious Diseases,
web site (www. ... 57 0.17 0.02 0.32 0.43 0.00 104.99 10.74 1. 1-1 0.50 0.07 0.00 ...
-

Source: Google Scholar
 
 

Toward New Medications For Iron-Overload Diseases

Journal of Medicinal Chemistry

Scientists report progress in developing much-needed new medications for hemochromatosis and other iron-overload diseases. In these conditions, excess amounts of iron accumulate in the liver, heart, pancreas and other organs and eventually cause serious damage.

Raymond J. Bergeron and colleagues at the University of Florida explain that existing treatments remove only small amounts of iron from sensitive organs like the heart. Treatment sometimes must continue for years to remove enough iron to prevent organ damage, they note in a report in the ACS Journal of Medicinal Chemistry, a biweekly publication.

The researchers report the synthesis and early testing in laboratory animals of a possible new generation of iron chelating drugs, compounds that remove excess iron from the body. In addition to working more efficiently than existing medications, the new compounds target specific organs such as the liver, heart and pancreas that are most vulnerable to iron-overload damage.

ARTICLE #1 "The Design, Synthesis, and Evaluation of Organ-Specific Iron Chelators"

###

ACS News Service Weekly PressPac -- Nov. 22, 2006

Contact: Michael Woods
American Chemical Society

Article continues below and (thank you)
 

Engineering The "Super Enzyme" -- A Potential New Weapon Against Heart Disease Biochemistry


Efforts to understand the link between the cyclooxygenase-2 (COX-2) inhibitor arthritis drugs and heart disease have had an unanticipated benefit in leading to development of an engineered protein with "great potential" as a new treatment for heart disease, according to a new scientific report.

In an article in ACS weekly journal Biochemistry, University of Texas's Ke-He Ruan and colleagues point out that the COX-2 drugs like the banned Vioxx have beneficial anti-inflammatory effects for arthritis. However, studies now suggest that those drugs also may increase the risk of heart attacks and strokes by decreasing the body's production of prostacyclin (a blood vessel protector that dilates blood vessels and prevents blood clots) and increasing production of thromboxane (which constricts vessels and promotes clot formation).

A drug that increases prostacyclin levels and decreases thromboxane could be an ideal way to prevent and treat inflammation and cardiovascular disease, they state. Ruan's group reports taking a step in that direction. They report linking together two enzymes to engineer a protein to form a "Super Enzyme" with three catalytic functions that makes cells grown in laboratory cultures continuously produce protective prostacyclin. The enzyme has advantages over another proposed strategy that involves increasing prostacyclin levels by administering the COX gene into cells, they add.

ARTICLE #3 "Engineering of a Protein with Cyclooxygenase and Prostacyclin Synthase Activities That Converts Arachidonic Acid to Prostacyclin"

###

ACS News Service Weekly PressPac -- Nov. 22, 2006

Contact: Michael Woods
American Chemical Society

 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 
 © 2002-2006

Keywords::

Contact Iconocast

Home Page